Orchiectomy and chemotherapy with estramustine, cis-platinum, cyclophosphamide, and 5-fluorouracil in newly diagnosed prostate cancer with bone metastases
- 30 June 1984
- Vol. 23 (6) , 51-53
- https://doi.org/10.1016/s0090-4295(84)80099-0
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Early combined hormonal and chemotherapy for metastatic prostatic carcinomaUrology, 1983
- Observations of prolonged use of oral emcyt in prostatic cancer patientsUrology, 1982
- The Influence of Hormonal Therapy on Survival of Men with Advanced Prostatic CancerJournal of Urology, 1982
- Estramustine phosphate (estracyt®) treatment of T3–T4 prostatic carcinomaThe Prostate, 1982
- Estramustine phosphate with multiple cytotoxic agents in treatment of advanced prostatic cancerUrology, 1981
- A Comparison of Hydroxyurea, Methyl-chloroethyl-cyclohexy-nitrosourea and Cyclophosphamide in Patients With Advanced Carcinoma of the ProstateJournal of Urology, 1981
- Treatment of previously untreated (by hormonal manipulation) stage D adenocarcinoma of prostate with combined orchiectomy, estrogen, and cis diamminedichloroplatinumUrology, 1980
- Treatment of Stage D Hormone-Resistant Carcinoma of the Prostate with Estramustine PhosphateJournal of Urology, 1979
- Comparison of Procarbazine, Imidazole-Carboxamide and Cyclophosphamide in Relapsing Patients with Advanced Carcinoma of the ProstateJournal of Urology, 1979
- The Continued Evaluation of the Effects of Chemotherapy in Patients with Advanced Carcinoma of the ProstateJournal of Urology, 1976